Gait Speed for Predicting Cardiovascular Events After Myocardial Infarction

Myocardial Infarction Clinical Trial

Official title:

Gait Speed for Predicting Cardiovascular Events After Myocardial Infarction

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01484158
• Other study ID #: Gait Speed Outcome Study
• Status: Completed
• Phase: N/A
• First received: November 30, 2011
• Last updated: January 20, 2015
• Start date: October 2001
• Est. completion date: December 2012

Study information

• Verified date: January 2015
• Source: Yokohama City University Medical Center
• Contact: n/a
• Is FDA regulated: No
• Health authority: Japan: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

There are growing evidences that gait speed is inversely associated with all causes mortality especially cardiovascular mortality among the elderly. The purpose of this study is to evaluate the predictive value of gait speed for cardiovascular events in patients after ST-segment elevation myocardial infarction (STEMI).

Description:

The investigators will enroll patients capable of walking with STEMI. All patients will receive successful reperfusion therapy within 12-hour from onset. Gait speed during cardiac rehabilitation is measured. Cardiovascular events were defined as a composite of cardiovascular death, non-fatal myocardial infarction and non-fatal stroke, for an average follow-up period.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 450
• Est. completion date: December 2012
• Est. primary completion date: December 2012
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 30 Years and older

Eligibility

Inclusion Criteria:

• Clinical diagnosis of ST-segment elevation acute myocardial infarction

• Must be treated within 12 hours after symptom onset

• Must be able to walk

• Must receive successful primary percutaneous coronary intervention

Exclusion Criteria:

• History of prior myocardial infarction

• Cerebrovascular disease with residual hemiplegia

• Severe peripheral arterial disease

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

• Infarction
• Myocardial Infarction

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Yokohama City University Medical Center

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Cardiovascular Events	cardiovascular death, non-fatal myocardial infarction and non-fatal stroke	5 years	No